|Bid||88.87 x 1300|
|Ask||90.22 x 1000|
|Day's Range||89.21 - 90.28|
|52 Week Range||65.35 - 90.28|
|Beta (5Y Monthly)||1.43|
|PE Ratio (TTM)||26.74|
|Earnings Date||Feb 17, 2020|
|Forward Dividend & Yield||0.72 (0.80%)|
|Ex-Dividend Date||Dec 28, 2019|
|1y Target Est||88.81|
Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking into the risk factors for atopic eczema (also known as atopic dermatitis), a chronic skin condition that affects one in five children and one in 12 adults.
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Pershing Square Holdings’ 2019 performance topped virtually all U.S. mutual funds and beat the S&P 500, which returned 31.5% including dividends. But it’s trading at a 28% discount to its net asset value.
Agilent Technologies Inc. (NYSE: A) today announced the latest implementation of its mutual compatibility philosophy. Now, joint customers of Agilent Technologies and Thermo Fisher Scientific can choose a chromatography data system from either company—Agilent OpenLab CDS or Thermo Fisher Chromeleon—to control analytical instruments from both organizations.
Agilent Technologies Inc. (NYSE: A) today announced that the company’s ability to help laboratories comply with government regulations has been ranked second to none in a global survey.
While the market driven by short-term sentiment influenced by the accomodative interest rate environment in the US, increasing oil prices and deteriorating expectations towards the resolution of the trade war with China, many smart money investors kept their cautious approach regarding the current bull run in the third quarter and hedging or reducing many of […]
Last week saw the newest full-year earnings release from Agilent Technologies, Inc. (NYSE:A), an important milestone...
Securities and Exchange Commission filings on Resideo, Rocket Pharma, GTT, and eight other companies
This article is written for those who want to get better at using price to earnings ratios (P/E ratios). To keep it...
U.S. traders looking to actively trade cannabis stocks have a new instrument to use in their trading toolkit. REX Shares, a Connecticut-based provider of exchange-traded products, announced today the launch of the MicroSectors Cannabis 2x Leveraged ETN (MJO), the first U.S.-listed leveraged cannabis product. “There is a void in the market for trading products around cannabis,” said Scott Acheychek, president of REX Shares.
The weakness from the end of Monday's session had follow through in the overnight session and had market participants preparing for a red day, until it was rumored the Dec. 15 tariffs on China were going to be delayed. Just after the close on Monday, it was announced Bill Ackman's Pershing Square amended 13F filing revealed a 2.916 million share stake in Agilent Technologies (NYSE: A).
The hedge fund owned nearly 3 million shares of the life-sciences company at the end of the third quarter. Agilent stock is beating the S&P 500 so far in the fourth quarter.
The main U.S. stock indexes were lower as investors awaited signs of progress on trade ahead of Sunday, when new tariffs on imports from China are to take effect.
Billionaire investor William Ackman's hedge fund Pershing Square Capital Management said Monday it bought shares in testing equipment company Agilent Technologies Inc, only its second new investment this year as the fund has reported a 51% return. Agilent Technologies' stock price jumped nearly 5% in after-hours trading after Ackman's investment was made public in a regulatory filing. Ackman's $7 billion fund earlier in the year bought Berkshire Hathaway Inc shares.
Agilent named as Best Workplace and Best Workplace for Women in Greater China.